Bangladesh - English - DGDA (Directorate General of Drug Administration)

globe pharmaceuticals ltd. - calcium chloride + d-pantothenol + dl-methionine + dextrose + l-arginine hcl + l-cysteine hcl + l-histidine hcl + l-isolencine + l-leucine + l-lysine hcl + l-phenylalamine + l-threonine + l-tryptophane + l-valine + magnesium sulphate + monosodium glutamate + nicotinamide + potassium chloride + pyridoxine + riboflavin + sodium acetate + thiamine hydrochloride - injection - 2 mg + .1 mg + .525 mg + 50 mg + 1.425 mg + .02 mg + .02 mg + .525 mg + .6 mg + .525 mg + .35 mg + .35 mg + .175 mg + .525 mg + 2 mg + .08 mg + 3 mg + 2 mg + .1 mg + .05 mg + 7.5 mg + .1 mg/ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

guardian healthcare ltd. - calcium chloride + d-pantothenol + dl-methionine + dextrose + l-arginine hcl + l-cysteine hcl + l-histidine hcl + l-isolencine + l-leucine + l-lysine hcl + l-phenylalamine + l-threonine + l-tryptophane + l-valine + magnesium sulphate + monosodium glutamate + nicotinamide + potassium chloride + pyridoxine + riboflavin + sodium acetate + thiamine hydrochloride - injection - 2 mg + .1 mg + .525 mg + 50 mg + 1.425 mg + .02 mg + .02 mg + .525 mg + .6 mg + .525 mg + .35 mg + .35 mg + .175 mg + .525 mg + 2 mg + .08 mg + 3 mg + 2 mg + .1 mg + .05 mg + 7.5 mg + .1 mg/ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

orion infusion ltd. - calcium chloride + d-pantothenol + dl-methionine + dextrose + l-arginine hcl + l-cysteine hcl + l-histidine hcl + l-isolencine + l-leucine + l-lysine hcl + l-phenylalamine + l-threonine + l-tryptophane + l-valine + magnesium sulphate + monosodium glutamate + nicotinamide + potassium chloride + pyridoxine + riboflavin + sodium acetate + thiamine hydrochloride - injection - 2 mg + .1 mg + .525 mg + 50 mg + 1.425 mg + .02 mg + .02 mg + .525 mg + .6 mg + .525 mg + .35 mg + .35 mg + .175 mg + .525 mg + 2 mg + .08 mg + 3 mg + 2 mg + .1 mg + .05 mg + 7.5 mg + .1 mg/ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - calcium chloride + d-pantothenol + dl-methionine + dextrose + l-arginine hcl + l-cysteine hcl + l-histidine hcl + l-isolencine + l-leucine + l-lysine hcl + l-phenylalamine + l-threonine + l-tryptophane + l-valine + magnesium sulphate + monosodium glutamate + nicotinamide + potassium chloride + pyridoxine + riboflavin + sodium acetate + thiamine hydrochloride - injection - 2 mg + .1 mg + .525 mg + 50 mg + 1.425 mg + .02 mg + .02 mg + .525 mg + .6 mg + .525 mg + .35 mg + .35 mg + .175 mg + .525 mg + 2 mg + .08 mg + 3 mg + 2 mg + .1 mg + .05 mg + 7.5 mg + .1 mg/ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

chemist laboratories ltd. - calcium chloride + d-pantothenol + dl-methionine + dextrose + l-arginine hcl + l-cysteine hcl + l-histidine hcl + l-isolencine + l-leucine + l-lysine hcl + l-phenylalamine + l-threonine + l-tryptophane + l-valine + magnesium sulphate + monosodium glutamate + nicotinamide + potassium chloride + pyridoxine + riboflavin + sodium acetate + thiamine hydrochloride - injection - 2 mg + .1 mg + .525 mg + 50 mg + 1.425 mg + .02 mg + .02 mg + .525 mg + .6 mg + .525 mg + .35 mg + .35 mg + .175 mg + .525 mg + 2 mg + .08 mg + 3 mg + 2 mg + .1 mg + .05 mg + 7.5 mg + .1 mg/ml

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.

United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a c

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and d

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unk

United States - English - NLM (National Library of Medicine)

lupin limited - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1) ]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are un